This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


06Jun 2019

Back to News overview

Biomarkers predict development breast cancer

In order to further improve the personalized treatment of breast cancer patients scientists are continuously searching for patient and tumor characteristics that could predict how patients will fare and which treatment will work best. Marcelo Sobral-Leite studied several of such biomarker during his PhD research. He discovered that the protein Annexin A1 can be valuable for predicting the breast cancer survival of patients in high risk groups, such as patients with HER2-positive cancers. He also investigated the predictive value of immune cells present in the tumor. He will defend his thesis at Utrecht University on June 11th. Good luck Marcelo!

Practical information about the defense can be found on UMC Utrecht's website.

Share this page